Skip to main navigation Skip to search Skip to main content

Prognostic and therapeutic implications of clinical-radiologic discrepancy in parametrial invasion prior to primary radical hysterectomy in cervical cancer

  • Ester P. Olthof
  • , Nicholai A. Oostveen
  • , Maaike A. van der Aa
  • , Ruud L. M. Bekkers
  • , Constantijne H. Mom
  • , Jacobus van der Velden
  • , Joost Nederend
  • , Edith M. G. van Esch*
  • *Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Aim: This study evaluates the prognostic and therapeutic implications of clinical-radiologic discrepancy in parametrial invasion of cervical cancer prior to radical hysterectomy. We compared patients with radiological presence but clinical absence of parametrial invasion (discrepancy group) to those without radiologic and clinical suspicion of parametrial invasion (consensus group). Methods: Women with International Federation of Gynaecology and Obstetrics (2009) stage IA-IIA cervical cancer, diagnosed between 2009 and 2017, who underwent magnetic resonance imaging prior to radical hysterectomy were retrospectively selected from the Netherlands Cancer Registry. Kaplan-Meier estimates and Cox proportional hazards were used for survival and logistic regression for risk of adjuvant therapy and toxicity. Results: Of 886 patients included, 87 (10%) had clinical-radiologic parametrial invasion discrepancy. Patients with discrepancy were more likely to have poor prognostic factors (i.e., a larger tumor, increased depth of invasion, lymphovascular space invasion, nodal metastases and positive resection margins) than those without. The 5-year disease-free and overall survival rates were lower in the discrepancy (74% and 82%) than in the consensus group (86% and 92%). However, after confounder adjustments, disease-free and overall survival were not affected by clinical-radiologic discrepancy. Patients with discrepancy in parametrial invasion were more likely to receive adjuvant therapy (54% vs 23%) and experience therapy-related toxicity (44% vs 29%). Conclusion: Clinical-radiologic discrepancy of parametrial invasion occurs in approximately 10% of patients and is associated with poor prognostic factors and increased likelihood of adjuvant therapy and toxicity. This highlights the importance of addressing these factors in treatment counselling for either primary chemoradiotherapy or surgery.
Original languageEnglish
Article number102002
Number of pages6
JournalGynecologic Oncology Reports
Volume63
Early online date1 Dec 2025
DOIs
Publication statusPublished - 1 Feb 2026

Keywords

  • Cervical cancer
  • Neoplasm Staging
  • FIGO classification
  • TNM staging
  • Magnetic Resonance Imaging
  • QUALITY-OF-LIFE
  • STAGE-IB
  • MULTICENTER
  • INVOLVEMENT
  • SURVIVAL
  • SURGERY
  • CARCINOMA
  • OUTCOMES
  • TRIAL
  • RISK

Fingerprint

Dive into the research topics of 'Prognostic and therapeutic implications of clinical-radiologic discrepancy in parametrial invasion prior to primary radical hysterectomy in cervical cancer'. Together they form a unique fingerprint.

Cite this